[DVT and combined oral contraceptives: update of the pluridisciplinary CNGOF-FNCGM-GEHT-SFMV group]

N Chabbert-Buffet; B Guigues; N Trillot; C Biron; P Morange; G Pernod; M Scheffler; S Brugere; B Hedon

doi:10.1016/j.jgyn.2013.03.015

[DVT and combined oral contraceptives: update of the pluridisciplinary CNGOF-FNCGM-GEHT-SFMV group]

J Gynecol Obstet Biol Reprod (Paris). 2013 Jun;42(4):309-15. doi: 10.1016/j.jgyn.2013.03.015. Epub 2013 May 1.

[Article in French]

Authors

N Chabbert-Buffet¹, B Guigues, N Trillot, C Biron, P Morange, G Pernod, M Scheffler, S Brugere, B Hedon

Affiliation

¹ Collège national des gynécologues-obstétriciens français (CNGOF), 91, boulevard de Sébastopol, 75002 Paris, France. [email protected]

PMID: 23642503
DOI: 10.1016/j.jgyn.2013.03.015

Abstract

Thrombotic risk among combined oral contraceptives (COC) users has recently been debated following a court action initiated by a patient. Recent epidemiological data, as well as accumulating biological data underlying these data, have led French Health authorities to modify COC prescription and reimbursement modalities. A short synthesis is proposed by a multidisciplinary group of experts from four French societies (CGOF, FNCGM, GHT, and SFMV).

Publication types

Review

MeSH terms

Contraceptives, Oral, Combined / adverse effects*
Contraindications
Female
France / epidemiology
Gynecology / organization & administration
Humans
Interdisciplinary Communication
Obstetrics / organization & administration
Practice Guidelines as Topic
Societies, Medical
Venous Thrombosis / chemically induced*
Venous Thrombosis / epidemiology*
Venous Thrombosis / prevention & control

Substances

Contraceptives, Oral, Combined